Apsen Pharmaceuticals

Name

Apsen Pharmaceuticals

Legal name

Apsen Farmacêutica S.A.

Website

https://apsen.com.br

Company type

Private

Founded year

1969

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Branded Pharmaceuticals

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

akta.pro secondary industries

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Pain Management & Anesthesiology Pharmaceuticals (HLAIAAAN), Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)

Keywords

• Branded pharmaceuticals
• Prescription medications
• Nutritional supplements
• Probiotic formulations
• Pharmaceutical manufacturing

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain

Revenue model

1. Prescription Medications: Core revenue from branded prescription pharmaceuticals across therapeutic areas including Neurology, Psychiatry, Otolaryngology, Urology, Gynecology, Rheumatology, Orthopedics, Gastroenterology, Geriatrics, Endocrinology, Angiology. Portfolio of 50+ medications with 14 exclusive products.
2. Nutritional Supplements: Functional food supplements including probiotics (Lactosil Flora, Probid), psychobiotics (Probians), and vitamins. Products sold through pharmacies targeting gastrointestinal health, mental health via gut-brain axis, and lactose intolerance.
3. Over-the-Counter (MIPs): Medications exempt from prescription (Medicamentos Isentos de Prescrição) as part of growing OTC portfolio alongside supplements.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels9 records

Core offering

Apsen manufactures and distributes a portfolio of 50+ branded prescription medications across therapeutic areas including Neurology, Psychiatry, Otolaryngology, Urology, Gynecology, Rheumatology, Orthopedics, Gastroenterology, Geriatrics, Endocrinology, and Angiology. The company also produces functional nutritional supplements including probiotics, psychobiotics, and vitamins. Products are sold through pharmacy chains and pharmaceutical distributors in Brazil, supported by a direct field sales force engaging physicians.

Product overview

Apsen Pharmaceuticals is a Brazilian pharmaceutical company with a diversified portfolio of 54+ products including prescription medications, supplements, and digital health platforms. The medication portfolio covers multiple therapeutic areas: Central Nervous System (Alois, Donaren, Inseris XR, Luratt), Musculoskeletal (Miosan, Flancox, Insit), Gastroenterology (Inilok, Lonium, Probid), Urology (Uro-vaxom, Retemic, Unoprost), Vascular (Dobeven, Zanidip), and Anti-infectives (Levoxin, Traturil). The supplement line includes functional products like Lactosil Flora (lactase + probiotic), Probid (probiotic with functional claim), and Probians (psychobiotic for gut-brain axis). Digital offerings include Sou Mais Vida patient program, Sala VIP Apsen for healthcare professionals, and health information portals like TDAH Levado a Sério. The company also operates internal digital platforms including the Nação Azul employee app and ApsenCast podcast. Major awards include PROFA DE OURO 2023 RX Champion, LUPA DE OURO awards for CNS and musculoskeletal products, and Innovation Leader Award 2023.

Differentiator

Problem solved

Functional benefit

Brands

• Sou Mais Vida: Customer relationship program providing access to prescribed products with exclusive benefits
• Sala VIP Apsen
• Nação Azul
• Lactosil Flora
• Probid
• Probians

Products and services

• Alois (Alois Comprimido, Alois Duo, Alois Gotas) Neurology prescription medication family for Alzheimer's disease treatment, containing memantine hydrochloride (Alois Comprimido, Alois Gotas) and donepezil + memantine combination (Alois Duo). Sold through pharmacies with medical prescription for treating neurological conditions in geriatric patients.
• Donaren / Donaren Retard / Inseris XR

Quantifiable outcome

• 70% of previously manual processes automated through ServiceNow implementation
• +7 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eight partnerships are on record, tiered core, flagship and minor.

• Rimini StreetcoreTechnology or Integration · 27 January 2025Partnership with Rimini Street to implement ServiceNow workflow automation over existing SAP ECC 6 ERP, avoiding costly migration to SAP S/4HANA. Enables enterprise-wide process automation, achieving 70% automation of previously manual processes.
• ServiceNowcoreTechnology or Integration · 27 January 2025ServiceNow platform implementation enabling enterprise workflow automation across Apsen operations, reducing process development cycles from months to weeks. Partnership announced at ServiceNow's Knowledge 2025 event.
• Hospital Israelita Albert EinsteinflagshipStrategic or Co-development Partner · 13 August 2024Historic partnership establishing the first Einstein Clinic in a national pharmaceutical industry at Apsen's headquarters. Provides excellence healthcare including Family Doctor, Family Nurse, Care Coordination team, Einstein Telemedicine, and Mental Health Program for all Apsen employees nationwide.
• SBU - Sociedade Brasileira de UrologiacoreStrategic or Co-development PartnerPartnership with Brazilian Urology Society (São Paulo and Rio de Janeiro sections) for FelizIdade campaign, raising awareness about Benign Prostatic Hyperplasia (BPH), providing free examinations and health information to Brazilian men.
• Abrafarma - Associação Brasileira de Redes de Farmácias e DrogariascoreGTM or Marketing PartnerPartnership with Brazilian Pharmacy Chains Association for healthcare awareness campaigns including FelizIdade campaign for prostate health, combining pharmacy reach with medical expertise.
• Coop - Cooperativa de ConsumominorGTM or Marketing PartnerSocial partnership providing free gynecological care in five locations in São Paulo as part of International Women's Day celebrations and women's health awareness initiatives.
• Lallemand (Canada)coreTechnology or IntegrationPartnership with Canadian laboratory Lallemand to produce Probians, Brazil's first psychobiotic supplement. Lallemand provides probiotic strains (Lactobacillus helveticus R0052 ND and Bifidobacterium longum R0175) with proven gut-brain axis efficacy.
• ProfarmacoreChannel Partner/ Reseller/ DistributorDistribution partnership with Profarma, the 2nd largest pharmaceutical distributor in Brazil. Recognition as PROFA DE OURO 2023 champion in RX category and TopFornecedor 2023 demonstrates strong commercial relationship.

Scale indicators10 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Eurofarma Laboratórios: One of Brazil's largest 100% national pharmaceutical companies, with a diversified branded generics and specialty pharma portfolio across CNS, women's health, and prescription medications. Directly comparable to Apsen in scale, Brazilian-only focus, family-influenced governance, and field-sales-driven GTM targeting physicians.
• EMS Pharma: Largest Brazilian pharmaceutical company by volume, with leadership in branded generics and a growing specialty and biosimilar franchise. Competes head-to-head with Apsen in CNS, urology, and gastroenterology categories and shares the same pharmacy-chain and distributor go-to-market.
• Mantecorp Farmasa: Brazilian pharmaceutical company with a portfolio spanning prescription and OTC products, including CNS, dermatology, and women's health. Comparable mid-tier Brazilian specialty pharma competing for similar physician mindshare and pharmacy shelf space.
• Aché Laboratórios Farmacêuticos: Major Brazilian pharmaceutical company with broad prescription and OTC portfolio spanning CNS, dermatology, respiratory, and musculoskeletal categories. Comparable in size, domestic focus, and therapeutic-area overlap with Apsen, and serves similar physician and pharmacy distribution channels.
• Biolab Farmacêutica: Brazilian pharmaceutical company focused on prescription specialties including cardiology, gynecology, dermatology, and CNS. Comparable as a mid-tier Brazilian specialty pharma with similar therapeutic-area mix and reliance on physician detailing.
• Cristália Produtos Químicos Farmacêuticos: Brazilian pharmaceutical company combining specialty pharma, hospital products, and APIs/manufacturing. Comparable to Apsen in domestic manufacturing focus and CNS portfolio, with additional hospital and institutional exposure.
• Hypera Pharma (Hyperabras / DM): Brazil's largest pharma company by revenue, formed through the consolidation of Hypermarcas and DM. Operates across prescription, OTC, and consumer health categories with a strong branded portfolio. Public-market listed (B3: HYPE3), providing a direct valuation benchmark for a scaled Brazilian specialty pharma peer.
• Libbs Farmacêutica: 100% Brazilian pharmaceutical company with a strong presence in women's health, CNS, dermatology, and specialty categories. Operates a similar prescription-pharma model with field sales force and pharmacy distribution, competing in overlapping therapeutic areas.

Broad incumbents

• Sanofi (Brazil operations): Global pharmaceutical company with a significant Brazil commercial presence spanning vaccines, specialty care, and primary care. Overlaps with Apsen in CNS, urology, and cardiovascular categories but at vastly larger scale and with global R&D; competes for the same specialist physicians in Brazil.
• Pfizer (Brazil operations): Global pharmaceutical incumbent with a major Brazil commercial footprint across primary care, specialty, and vaccines. Competes with Apsen in CNS and urology categories (e.g., pregabalin, OAB) and represents the multinational benchmark for therapeutic-area scale and R&D capacity in Brazil.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/ApsenFarma
• Facebookfacebook.com/ApsenFarmaceutica
• LinkedInlinkedin.com/company/apsen
• Instagraminstagram.com/apsenfarmaceutica/?hl=pt-br

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Apsen Pharmaceuticals